150 related articles for article (PubMed ID: 35101236)
21. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction.
Inder KL; Lau C; Loo D; Chaudhary N; Goodall A; Martin S; Jones A; van der Hoeven D; Parton RG; Hill MM; Hancock JF
J Biol Chem; 2009 Oct; 284(41):28410-28419. PubMed ID: 19661056
[TBL] [Abstract][Full Text] [Related]
22. Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
Michael JV; Goldfinger LE
Semin Cancer Biol; 2019 Feb; 54():121-130. PubMed ID: 29203271
[TBL] [Abstract][Full Text] [Related]
23. Lipid Profiles of RAS Nanoclusters Regulate RAS Function.
Zhou Y; Hancock JF
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680072
[TBL] [Abstract][Full Text] [Related]
24. Biophysical mechanism for ras-nanocluster formation and signaling in plasma membrane.
Gurry T; Kahramanoğullari O; Endres RG
PLoS One; 2009 Jul; 4(7):e6148. PubMed ID: 19587789
[TBL] [Abstract][Full Text] [Related]
25. SIGNAL TRANSDUCTION. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling.
Zhou Y; Wong CO; Cho KJ; van der Hoeven D; Liang H; Thakur DP; Luo J; Babic M; Zinsmaier KE; Zhu MX; Hu H; Venkatachalam K; Hancock JF
Science; 2015 Aug; 349(6250):873-6. PubMed ID: 26293964
[TBL] [Abstract][Full Text] [Related]
26. Compartmentalized signalling: Ras proteins and signalling nanoclusters.
Omerovic J; Prior IA
FEBS J; 2009 Apr; 276(7):1817-25. PubMed ID: 19243428
[TBL] [Abstract][Full Text] [Related]
27. Nanoclustering as a dominant feature of plasma membrane organization.
Garcia-Parajo MF; Cambi A; Torreno-Pina JA; Thompson N; Jacobson K
J Cell Sci; 2014 Dec; 127(Pt 23):4995-5005. PubMed ID: 25453114
[TBL] [Abstract][Full Text] [Related]
28. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth.
Tan L; Cho KJ; Neupane P; Capon RJ; Hancock JF
J Biol Chem; 2018 Aug; 293(35):13696-13706. PubMed ID: 29970615
[TBL] [Abstract][Full Text] [Related]
29. Caveolae regulate the nanoscale organization of the plasma membrane to remotely control Ras signaling.
Ariotti N; Fernández-Rojo MA; Zhou Y; Hill MM; Rodkey TL; Inder KL; Tanner LB; Wenk MR; Hancock JF; Parton RG
J Cell Biol; 2014 Mar; 204(5):777-92. PubMed ID: 24567358
[TBL] [Abstract][Full Text] [Related]
30. What drives the clustering of membrane-bound Ras?
Li Z; Gorfe AA
Small GTPases; 2012; 3(4):244-7. PubMed ID: 22935734
[TBL] [Abstract][Full Text] [Related]
31. Mathematical modeling of K-Ras nanocluster formation on the plasma membrane.
Tian T; Plowman SJ; Parton RG; Kloog Y; Hancock JF
Biophys J; 2010 Jul; 99(2):534-43. PubMed ID: 20643072
[TBL] [Abstract][Full Text] [Related]
32. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
Nussinov R; Tsai CJ; Jang H
Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
[TBL] [Abstract][Full Text] [Related]
33. RAS GTPases and Interleaflet Coupling in the Plasma Membrane.
Liu J; Arora N; Zhou Y
Cold Spring Harb Perspect Biol; 2023 Sep; 15(9):. PubMed ID: 37463719
[No Abstract] [Full Text] [Related]
34. H-Ras dynamically interacts with recycling endosomes in CHO-K1 cells: involvement of Rab5 and Rab11 in the trafficking of H-Ras to this pericentriolar endocytic compartment.
Gomez GA; Daniotti JL
J Biol Chem; 2005 Oct; 280(41):34997-5010. PubMed ID: 16079139
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic K-ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status.
Barceló C; Paco N; Beckett AJ; Alvarez-Moya B; Garrido E; Gelabert M; Tebar F; Jaumot M; Prior I; Agell N
J Cell Sci; 2013 Oct; 126(Pt 20):4553-9. PubMed ID: 23943869
[TBL] [Abstract][Full Text] [Related]
36. Ras assemblies and signaling at the membrane.
Nussinov R; Tsai CJ; Jang H
Curr Opin Struct Biol; 2020 Jun; 62():140-148. PubMed ID: 32032914
[TBL] [Abstract][Full Text] [Related]
37. K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.
Shalom-Feuerstein R; Plowman SJ; Rotblat B; Ariotti N; Tian T; Hancock JF; Kloog Y
Cancer Res; 2008 Aug; 68(16):6608-16. PubMed ID: 18701484
[TBL] [Abstract][Full Text] [Related]
38. High-throughput, single-particle tracking reveals nested membrane domains that dictate KRas
Lee Y; Phelps C; Huang T; Mostofian B; Wu L; Zhang Y; Tao K; Chang YH; Stork PJ; Gray JW; Zuckerman DM; Nan X
Elife; 2019 Nov; 8():. PubMed ID: 31674905
[TBL] [Abstract][Full Text] [Related]
39. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
Aguilar BJ; Zhou H; Lu Q
Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
[TBL] [Abstract][Full Text] [Related]
40. Rasosomes spread Ras signals from plasma membrane 'hotspots'.
Kofer-Geles M; Gottfried I; Haklai R; Elad-Zefadia G; Kloog Y; Ashery U
Biochim Biophys Acta; 2009 Nov; 1793(11):1691-702. PubMed ID: 19695294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
